Patent Assignment
Reel/Frame 027458/0332
Assignment of Assignor's Interest
Recorded: 2011-12-29
Pages: 20
Assignors
AKINC, AKIN
Executed: 2011-08-31
QUERBES, WILLIAM
Executed: 2011-08-31
WONG, FRANCES M.P.
Executed: 2011-11-22
DORKIN, JOSEPH R
Executed: 2011-09-13
QIN, XIAOJUN
Executed: 2011-08-31
CANTLEY, WILLIAM
Executed: 2011-09-13
BORODOVSKY, ANNA
Executed: 2011-09-13
DE, SOMA
Executed: 2011-09-23
MANOHARAN, MUTHIAH
Executed: 2011-09-13
JAYARAMAN, MUTHUSAMY
Executed: 2011-08-15
RAJEEV, KALLANTHOTTATHIL G
Executed: 2011-09-06
Assignee
ALNYLAM PHARMACEUTICALS, INC.
300 THIRD STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(2)
Improved Lipid Formulation
PCT:
PCT/US2010/022614 ↗
Lipid Formulation
Application:
13/147,189 →
Publication:
US 2012/0101148
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 21, 2013
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 029852/0306 →
Assignment of Assignor's Interest
Apr 3, 2013
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 030143/0852 →
Change of Name
Mar 17, 2017
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 041625/0507 →
Merger and Change of Name
Jul 27, 2018
From: PROTIVA BIOTHERAPEUTICS INC.; ARBUTUS BIOPHARMA CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 046640/0764 →
Merger and Change of Name
Jul 27, 2018
From: PROTIVA BIOTHERAPEUTICS INC.; ARBUTUS BIOPHARMA CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 046657/0254 →